Central Pharmaceuticals Ltd. (DSE: CENTRALPHL)
Bangladesh
· Delayed Price · Currency is BDT
14.50
-0.40 (-2.68%)
At close: Sep 12, 2024
Central Pharmaceuticals Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 11, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 |
Market Capitalization | 1,737 | 1,486 | 1,569 | 1,581 | 1,593 | 1,509 | |
Market Cap Growth | 203.96% | -5.34% | -0.76% | -0.75% | 5.56% | -12.96% | |
Enterprise Value | 2,023 | 1,752 | 1,818 | 1,803 | 1,818 | 1,708 | |
Last Close Price | 14.50 | 12.40 | 13.10 | 13.20 | 13.30 | 12.45 | |
PE Ratio | - | -33.79 | -23.00 | -186.71 | -1.44 | 26.13 | |
PS Ratio | 15.91 | 50.65 | 60.37 | 10.67 | 11.37 | 4.91 | |
PB Ratio | 2.04 | 2.22 | 2.20 | 2.02 | 2.02 | 0.85 | |
P/FCF Ratio | -29188.88 | -4557.12 | -1401.94 | -331.10 | -3924.39 | -1631.13 | |
P/OCF Ratio | -29188.88 | -4557.12 | -1401.94 | 880.40 | -3924.39 | 146.18 | |
EV/Sales Ratio | 18.10 | 59.75 | 69.92 | 12.17 | 12.97 | 5.55 | |
EV/EBITDA Ratio | -191.60 | -83.01 | -77.05 | 45.42 | -1.71 | 12.30 | |
EV/EBIT Ratio | -87.66 | -36.62 | -34.07 | 264.59 | -1.65 | 17.29 | |
EV/FCF Ratio | -31405.92 | -5376.01 | -1623.80 | -377.60 | -4476.73 | -1845.37 | |
Debt / Equity Ratio | 0.34 | 0.40 | 0.38 | 0.32 | 0.29 | 0.12 | |
Debt / EBITDA Ratio | - | - | - | 6.33 | - | 1.48 | |
Debt / FCF Ratio | -2274.52 | -823.59 | -239.83 | -52.64 | -557.18 | -222.02 | |
Asset Turnover | - | 0.02 | 0.02 | 0.11 | 0.07 | 0.13 | |
Inventory Turnover | - | 1.90 | 1.26 | 2.06 | 1.95 | 0.29 | |
Quick Ratio | 0.34 | 0.25 | 0.25 | 0.26 | 0.20 | 1.13 | |
Current Ratio | 1.18 | 1.18 | 1.25 | 1.37 | 1.31 | 2.76 | |
Return on Equity (ROE) | - | -6.35% | -9.12% | -1.08% | -86.06% | 3.19% | |
Return on Assets (ROA) | - | -2.32% | -2.49% | 0.31% | -35.91% | 2.55% | |
Return on Capital (ROIC) | - | -3.11% | -3.31% | 0.42% | -45.76% | 3.09% | |
Earnings Yield | -3.33% | -2.96% | -4.35% | -0.54% | -69.48% | 3.78% | |
FCF Yield | -0.00% | -0.02% | -0.07% | -0.30% | -0.03% | -0.06% | |
Dividend Yield | 0.00% | - | - | - | - | 0.80% | |
Buyback Yield / Dilution | -2.36% | - | - | - | - | - | |
Total Shareholder Return | -2.36% | - | - | - | - | 0.80% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.